The in vitro regulation of fetal hemoglobin (Hb F) was investigated in clones of cultured adult human erythroid cells by in situ immunofluorescent identification of the hemoglobins synthesized. Formation of Hb F-containing clones was enhanced by erythropoietin and by culture conditions favoring the proliferation of less-differentiated stem cells of the burstforming-unit type. Burst-forming units differed in their capacity to direct Hb F synthesis in their terminally differentiated progeny. A class of early precursors that can produce descendent stem cells with or without commitment to H F production was identified. The findings suggest that the capability for expression of Hb F in terminally differentiated cells of the adult is determined at the level of less-differentiated erythroid stem cells with characteristics of burst-forming units. It is proposed that the regulation of Hb F synthesis in vivo is also linked to the process of differentiation of the erythroid stem cells and that the patterns of Hb F synthesis during ontogeny reflect the attainment of progressively higher levels of differentiation of erythroid stem cells as development proceeds. Hb F is the major Hb component during intrauterine life, but it is almost completely replaced by adult Hb soon after birth, so that only trace amounts, restricted to a few erythrocytes, are synthesized in the normal adult (1, 2). The mechanism of regulation of Hb F remains unclear.
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In a previous study (3), we showed that, when hemopoietic cells from adults are cultured under conditions permitting proliferation of erythroid cells in a clonal fashion, increased amounts of Hb F are synthesized. In addition, the in vitro erythroid clones differ in their ability to express Hb F synthesis and segregate into clones with absence of Hb F production and others with homogeneous presence of Hb F in their cells. Because each clone derives from a single stem cell progenitor, these observations revealed a heterogeneity among erythroid stem cells regarding their ability to direct Hb F synthesis in their terminally differentiated progeny (3) . In the present study we examined whether the heterogeneity of expression of Hb F in erythroid clones is related to the degree of differentiation of the progenitor cells from which the clones were derived.
Current models of erythropoiesis indicate that hemopoietic stem cells, once committed to the erythroid cell pathway, undergo an amplification process accompanied by the appearance of differentiated properties such as the ability to respond to erythropoietin (4) . This process is partly uncovered in vitro under selective culture conditions favoring proliferation of less-differentiated erythroid stem cells-defined as burstforming units, erythroid (BFUe)-or more differentiated precursors-colony-forming units, erythroid (CFUe). The CFUe are sensitive to erythropoietin and give rise to earlyAbbreviations: BFUe, burst-forming units, erythroid; CFUe, colony forming units, erythroid; anti-Hb F-FITC, anti-Hb F antibody conjugated with fluorescein isothiocyanate; anti-Hb S-FITC, anti-Hb S conjugated with FITC; anti-Hb C-FITC, anti-Hb C conjugated with FITC; F-colony, Hb F-containing colony; S-colony, Hb S-containing colony; C-colony, Hb C-containing colony.
appearing erythroid colonies (5-7). The BFUe require higher erythropoietin levels for growth, have higher proliferative capacity than the CFUe, and have an ability to give rise to clusters of erythroid colonies (erythroid bursts) that appear later than the colonies originating from CFUe (5-7). These differences in the in vitro behavior of CFUe and BFUe were utilized in the present study in order to examine the relationship between erythroid stem cell differentiation and Hb F synthesis. The results indicate that the phenotypic expression of Hb F in erythroid clones is largely dependent on the level of differentiation of the parental stem cells from which the clones derive and that regulatory decisions about y chain synthesis in erythroblasts are taken in primitive cells with the in vitro proliferative characteristics of BFUe.
METHODS
Bone Marrow Cultures from Normal Adults. The plasma clot culture system was used as described (3) with the exception that fetal calf serum was replaced by adult human serum. Effects of erythropoietin on Hb F formation were tested in cultures maintained for [8] [9] days in the presence of 0.25, 2.0, or 8.0 international units (IU) of erythropoietin (anemic sheep plasma erythropoietin step III preparation, Connaught Research Laboratories, Toronto, Canada) per ml of medium. For temporal observations of Hb F formation in culture, erythroid colonies were evaluated at various intervals and mostly at the peak formation of early-appearing (8-9 days) and late-appearing (14-16 days) colonies; erythropoietin concentrations (per ml of medium) were 2.0 IU (14 experiments) and 0.25 or 0.5 IU (8 experiments). Cell inocula contained 5 X 104 nucleated cells per ml.
Peripheral Blood Cultures. Samples of blood collected in NCTC-109 (Microbiological Associates, Bethesda, MD) containing 2% (vol/vol) fetal calf serum, penicillin (50 IU/ml), streptomycin (50,g/ml), and heparin (10 IU/ml) were layered over Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) in 50-ml centrifuge tubes. After 60 min of centrifugation at 400 X g at room temperature, interphase mononuclear cells were removed, washed twice in fresh medium, adjusted to approximately 1 X 107 cells per ml, and incubated for 2 hr at 370 in tissue culture flasks. The recovered nonadhering cells were cultured in plasma clots in the presence of adult human serum and 4.0 IU of erythropoietin. Cultures were evaluated with immunochemical and cytochemical staining at days 11 and 13. Antibodies and Immunofluorescent Labeling. Antibodies against Hb F (anti-Hb F), hemoglobin S (anti-Hb S), and hemoglobin C (anti-Hb C) were raised in horses and purified by affinity chromatography as described (2, 9) . Anti-Hb F sera were absorbed against Sepharose-Hb S and Sepharose-Hb C, anti-Hb S sera against Sepharose-Hb C, and anti-Hb C sera against Sepahrose-Hb S. Conditions of in situ labeling with In the first, precursor cells of high or low erythropoietin sensitivity were stimulated for growth by varying the erythropoietin concentrations in the culture medium (5, 7, 10) . In the second, colony populations were distinguished on the basis of differences in time of appearance of CFUe-and BFUe-origin colonies in culture (6, 7) .
F-colony frequencies in adult human marrow cultures maintained for 8-9 days in the presence of three erythropoietin concentrations are shown in Table 1 . Despite the variation between marrows, a positive correlation between erythropoietin level and proportion of F-colonies was observed. At the erythropoietin levels used, 7, 29.6, and 51.2 F-colony forming cells, respectively, were recovered per 105 inoculated nucleated cells. The data suggest that F-colony forming cells have high erythropoietin requirements for in vitro growth.
F-colony formation in two periods of colony growth in the presence of a high erythropoietin, stimulus (2.0 IU/ml of medium) is depicted in Table 2 . In human marrow cultures, early erythroid colonies of CFUe origin show a peak growth at 7-9 days of culture and subsequently disintegrate; with application of high erythropoietin stimuli, a wave of immature colonies of BFUe origin appears at 8-11 days of culture and they achieve maximal mature growth at days [14] [15] [16] . Cultures observed at 8-9 days produced 221.4 + 21.5 (mean +SEM) colonies per HP inoculated cells, 13 .1% + 1.5 of which were F-colonies. In the 14-to 16 -day cultures, there was an average of 151.9 + 23.2 erythroid colonies per 105 inoculated cells (the decrease reflecting the disappearance of colonies of CFUe origin) with a frequency of F-colonies of 34.1% + 3.9. The absolute number of F-colonies among late colonies was increased by a factor of 1.76 over that in the 8-to 9-day cultures (from 28.9 ± 4.8 to 50.8 + 8.4 per 105 inoculated nucleated cells), indicating that the increased frequency of F-colonies among the late colony population was due to new F-colony formation. Similar information was obtained in five experiments (among eight attempts) in which growth of late colonies was achieved at low erythropoietin levels (0.25 or 0.5 IU/ml of medium).
Expression of Hb F in Erythroid Bursts. Bone marrow and blood cultures (both initiated with low cell inocula) containing discrete erythroid bursts were used to examine the expression of Hb F in the subcolonies composing each burst. Labeling with anti-Hb F-FITC revealed three patterns of Hb F formation in well-hemoglobinized bursts: (i) F-subcolonies only (Fig. 1) ; (ii) bursts in which subcolonies had no detectable levels of Hb F (Fig. 1) ; and (iii) bursts with a significant variation in intensity of fluorescence among subcolonies as well as subcolonies showing sectorial appearance of Hb F (Fig. 2) . In peripheral blood cultures from two normal persons, the frequencies of the three types of bursts were 5-10%, 3040%, and 50-60% for burst types 1, 2, and 3, respectively.
To determine whether, in the third type of bursts, a single BFUe was responsible for formation of subcolonies with Hb F as well as of subcolonies without Hb F, the single-cell origin of erythroid bursts was examined. An artificial mosaic was established by coculturing stem cells from two persons, one homozygous for Hb C and the other homozygous for Hb S. The genetic identity of the colonies composing each erythroid burst was then determined by sequential immunofluorescent labeling with anti-Hb S-FITC and anti-Hb C-FITC (Fig. 3) . In cultures initiated with low cell inocula, bursts containing only Hb S subcolonies or only Hb C subcolonies were observed, and no discrete erythroid bursts containing both types of subcolonies were noted, providing direct evidence for single BFUe origin of the colonies comprising each erythroid burst.
Cultures of this artificial mosaic, first labeled with anti-Hb by the direct study of Hb F production in the subcolonies of erythroid bursts; it revealed existence of differentiative heterogeneity among BFUe regarding their ability to direct Hb F synthesis in their progeny-subcolonies. This (2, 11) , the reversion to a fetal pattern of Hb formation in certain hematologic malignancies (12, 13) , and the reappearance of Hb F during the regeneration phase after bone marrow transplantation (14) all are in accordance with proliferation, in the adult hemopoietic tissue, of stem cells with ability to direct Hb F formation. The suggested derivation of Hb F-containing cells in the adult from a separate stem cell line (13) of (by definition) pluripotent stem cells is not supported by the present findings in culture. Because, as shown here, early erythroid precursors can provide progeny that differ in commitment to Hb F synthesis, erythrocytes in vivo that contain Hb F as well as those that do not must share common erythroid stem cell progenitors. If the commitment to Hb F were made at the pluripotent stem cell level, only two classes of erythroid bursts would have been observed (with either presence or absence of Hb F synthesis but not both). It thus appears more likely that mechanisms of Hb F regulation synchronized with other processes of differentiation of erythroid stem cells operate in vivo.
Previous workers have suggested that the regulation of the synthesis of Hb F is accomplished through the action of regulatory genes on the closely linked y and (3 hemoglobin loci (15, 16) , the sequential excisions of globin genes during development FIG. 4 (17) , the selective proliferation of precursors programmed for Hb F formation (18) , or a translational control operating in less-differentiated cells (19) . Other studies have failed to reveal translational (20) or globin gene excision mechanisms (21, 22) in Hb F regulation. We would like to indicate that a stem cell differentiation-dependent model of regulation of Hb F synthesis could account for the observations in viwo as well as the findings in culture.
We propose that the in vivo expression of Hb F is inversely related to the level of differentiation of erythroid stem cells, so that erythroblasts derived from earliest precursors synthesize mostly Hb F while those derived from fully differentiated stem cells produce only adult Hb (Fig. 5) . The patterns of Hb F production during normal ontogeny can then be attributed to the proliferation of erythroid stem cells of successively higher levels of differentiation as development proceeds. We suggest that the drastic change in erythropoiesis around the perinatal period induces stem cell differentiation to progress first to a level at which commitment to Hb F is decided in a stochastic fashion (Figs. 2 and 4) and finally to a level at which commitment to Hb F is lost; the switch from fetal to adult Hb formation is thus viewed as a reflection of changes in cell kinetics rather than direct action of inducers or repressors (15, 16) on the non-a-globin genes. In the normal adult, the erythroid precursors complete their differentiation process, so that production of Hb F occurs only in an occasional erythroblast that derives directly from less-differentiated precursors. Under the proposed mechanism, the reactivation of Hb F synthesis in certain diseases of adults represents secondary alteration of the kinetics of differentiation or proliferation of erythroid stem cells, leading to terminal differentiation of earlier erythroid precursors or precursors at different stages of responsiveness to factors affecting erythroid stem cell proliferation.
